BRIEF

on Moderna, Inc. (NASDAQ:MRNA)

Moderna Recognized as Top Employer for Tenth Consecutive Year

Stock price chart of Moderna, Inc. (EBR:MRNA) showing fluctuations.

Moderna, Inc. has been named a top employer in the global biopharmaceutical sector by Science and Science Careers' 2024 Top Employers Survey. This marks the tenth consecutive year that Moderna receives this accolade. The company's commitment to innovation, respect for employees, and social responsibility were cited as key factors in this recognition.

CEO Stéphane Bancel highlighted Moderna's focus on a digital-first, inclusive work environment. In 2024, the company collaborated with OpenAI to implement ChatGPT Enterprise, enhancing operational efficiency. Moderna also centralized its workforce at a new global headquarters in Cambridge, Massachusetts, and continued manufacturing expansion in Marlborough.

Chief Human Resources Officer Tracey Franklin emphasized the company's unwavering dedication to excellence and maintaining a workplace where curiosity and purpose are prioritized. The survey included over 6,400 respondents, primarily from biotechnology, biopharmaceutical, and pharmaceutical sectors worldwide.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Moderna, Inc. news